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Abstract 
Plants of the genus Crinum (Amaryllidaceae) are widely used in folk medicine in 
different tropical and subtropical regions around the world. The Indian species 
Crinum latifolium (L.) was traditionally used to treat rheumatism, fistula, tumors, 
earaches, rubefacient, tubercle and whitlow. In Vietnamese and Chinese 
traditional medicine Crinum latifolium preparations are used until nowadays 
because of their antiviral and antitumor properties. In this study, we 
demonstrate potent in vitro antioxidant activity of an aqueous Crinum latifolium 
extract by an oxygen radical absorbance capacity (ORAC) value of 1610 ± 150 
µmol Trolox equivalents/g. Furthermore, significant anti-inflammatory effects of 
this extract were shown by its potential to suppress indoleamine 
2,3-dioxygenase (IDO) mediated tryptophan degradation in unstimulated- and 
mitogen-stimulated PBMC at IC50 doses of 241 ± 57 µg/ml and 92 ± 20 µg/ml, 
respectively. Concentrations of the immune activation marker neopterin were 324 M.  Jenny  et al.:  
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slightly diminished in unstimulated PBMC, whereas a dose-dependent inhibition 
of neopterin formation was observed in mitogen-stimulated PBMC (IC50 = 453 ± 
86 µg/ml). Additionally, we measured also dose-dependent inhibitory effects of 
this aqueous Crinum latifolium extract on cell proliferation of highly metastatic 
human prostate carcinoma PC3 cells (IC50 = 4.5 ± 0.8 mg/ml), androgen-
sensitive prostate adenocarcinoma LNCaP cells (IC50 =2.3 ± 0.1 mg/ml), and 
benign prostate hyperplasia BPH-1 cells (IC50 = 2.1 ± 0.04 mg/ml). We conclude 
that both effects, inhibition of tumor cell growth and recovery of immune 
functions, are important for the antitumor properties of Crinum latifolium.  
Keywords 
Crinum latifolium (L.) • Peripheral blood mononuclear cells • Indoleamine 2,3-dioxygenase 
• Prostate cells • Proliferation 
Introduction 
Plants of the genus Crinum (Amaryllidaceae) comprise about 130 species which are pan-
tropically distributed and widely used in folk medicine in different geographical regions 
around the world. Extracts of Crinum species are reported to exert antitumor, 
immunostimulating, analgesic, antiviral, antibacterial and antifungal effects, which have 
been mainly attributed to the more than 150 alkaloids of the Amaryllidaceae type present 
in Crinum species [1, 2]. The Indian species Crinum latifolium (L.) was traditionally used to 
treat rheumatism, fistula, tumors, earaches, rubefacient, tubercle and whitlow [3,  4]. In 
Vietnamese and Chinese traditional medicine hot aqueous extracts of Crinum latifolium 
are used until nowadays because of its antiviral and antitumor activity, especially to treat 
prostate cancer [5,  6]. Scientific evidence for an antitumor effect of Crinum latifolium 
constituents emerged from an aqueous extract of Crinum latifolium leaves, which was 
found to retard growth of chemically induced 20-methylcholanthrene tumors in rats [7]. The 
same extract was also shown to activate and stimulate T-cell proliferation of human 
peripheral blood mononuclear cells (PBMC) and also in vivo following treatment of Balb/c 
mice [8]. Recent in vitro studies in our laboratory showed that hot and cold aqueous 
extracts of Crinum latifolium were highly active to suppress mitogen- and interferon 
(IFN)-γ-induced formation of the pteridine derivative neopterin in PBMC [9]. 
During the Th-1 type immune response, activated cells release large amounts of cytokines 
such as interleukin-(IL)-2 or IFN-γ. Pro-inflammatory IFN-γ is an important mediator of the 
innate and adaptive immune response triggering a variety of physiological and cellular 
responses e.g. induction of high amounts of antimicrobial and cytocidal reactive oxygen 
species (ROS) by macrophages and other cells [10].  In human macrophages, IFN-γ 
induces also the enzyme indoleamine 2,3-dioxygenase (IDO), which catalyses the rate-
limiting step of tryptophan degradation via the kynurenine pathway, and formation of the 
immune activation marker neopterin, via induction of the enzyme guanosine-triphosphate-
(GTP)-cyclohydrolase [11, 12]. IDO plays a central role in the suppression of intracellular 
bacteria and viruses during an antimicrobial immune response and also growth of 
malignant cells, as ongoing tryptophan degradation limits protein biosynthesis due to 
deprivation of this essential amino acid [13, 14]. More recently, it has been demonstrated 
in vitro that also T cell proliferation is inhibited efficiently by IDO [15,  16]. Increased   Crinum Latifolium Leave Extracts Suppress Immune Activation Cascades in Peripheral Blood …  325 
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tryptophan degradation and neopterin production develop in patients during diseases 
which are associated with Th1-type immune activation such as infections, autoimmune 
diseases, malignant disorders, and during allograft rejection episodes [11,  17,  18]. In 
patients, accelerated tryptophan degradation was found to parallel, and even to predict, 
the future course of several clinical conditions, including HIV infection, malignancy and 
autoimmune syndromes such as rheumatoid arthritis [18–20]. 
In this study, we evaluated the effects of powdered Crinum latifolium leaves extracted in 
water on the T-cell/macrophage interplay by its influence on PBMC stimulated with 
phytohaemagglutinin (PHA), which activates formation of IFN-γ in T-cells and 
subsequently tryptophan degradation and neopterin production in macrophages [21]. In an 
approach to measure the antioxidant capacity of this Crinum latifolium extract, we applied 
the oxygen radical absorption capacity (ORAC) assay. In addition, antiproliferative effects 
of this Crinum latifolium extract were analyzed in human benign prostate hyperplasia 
BPH-1 cells, highly metastatic prostate carcinoma PC3 cells, and androgen-sensitive 
prostate adenocarcinoma LNCaP cells. 
Results and Discussion 
Antioxidant activity in vitro 
The antioxidant capacity of Crinum latifolium extracted in water was evaluated using the 
ORAC assay, which measures the direct capacity of chain-breaking antioxidants based on 
the hydrogen atom transfer mechanism. Crinum latifolium showed potent peroxyl-radical 
scavenging capacity in vitro, with an ORAC value of 1610 ± 150 µmol TE/g. This ORAC 
value appears to be remarkably high in comparison to the ORAC values of other herbs. In 
a study of Liao et al. e.g., analysis of water extracts of 45 herbs traditionally used in 
chinese medicine revealed a very broad range of activity in the ORAC assay (40–1990 
µmol TE/g herbs), of which only two herbal extracts (Spatholobus suberectus: 1990 µmol 
TE/g; Sanguisorba officinalis: 1940 mmol TE/g) showed a higher ORAC value than the 
Crinum latifolium extract analyzed in this study [22]. 
Anti-inflammatory activity 
The aqueous extract of Crinum latifolium produced a strong anti-inflammatory effect on 
mitogen stimulated PBMC by counteracting both, mitogen-induced activation of IDO 
enzyme activity and secretion of neopterin, which directs to a down-regulatory effect of 
Crinum latifolium constituents on activated T-cells and production of IFN-γ In resting 
PBMC, the Crinum latifolium extract also suppressed tryptophan degradation mediated by 
spontaneous IDO activity and slightly diminished neopterin production. Suppression of 
IFN-γ formation and associated down-stream pathways agrees well with earlier findings by 
us and others, that compounds and extracts with antioxidant capacities (such as vitamin C 
and E, resveratrol, wine or extracts of cacao, green or black tea) exhibit strong 
suppressive effects on stimulated PBMC, similarly as the Crinum latifolium extract used in 
this study [9, 23–27]. 
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Tab. 1.   Concentrations of tryptophan, kynurenine, neopterin and kyn/trp in the 
supernatant of unstimulated and phytohaemagglutinin (PHA; 10 μg/ml)-
stimulated PBMC. 
 Unstimulated
a  PHA [10 µg/ml]
a 
Tryptophan [µmol/L  21.2 ± 1.6    2.6 ± 1.0** 
Kynurenine [µmol/L]    2.4 ± 0.6    9.9 ± 0.7** 
Kyn/trp [µmol/mmol]  119 ± 15  4658 ± 832** 
Neopterin [nmol/L]    4.7 ± 0.5  16.2 ± 1.8** 
a mean of 4 runs ± S.E.M. ** p <0.005, compared to unstimulated cells. 
 
The supernatants of unstimulated PBMC, cultivated for 48 hours under standard cultivation 
conditions, contained 21.1 ± 1.6 μmol/L tryptophan and 2.4 ± 0.6 μmol/L kynurenine 
resulting in a kynurenine to tryptophan ratio (kyn/trp) of 119 ± 15 µmol/mmol, as a 
measure of spontaneous IDO activity (Table 1). Upon treatment of PBMC with PHA 
[10  µg/ml] for 48 hours, tryptophan content decreased to 2.6 ± 1.0 μmol/L whereas 
kynurenine concentrations increased concomitantly to 9.9 ± 0.7 μmol/L, indicating an 
approximately 40-fold increase of IDO activity (4658 ± 832 µmol/mmol; Table 1). At the 
same time, neopterin concentrations raised from 4.7 ± 0.5 nmol/L in unstimulated cultures 
to 16.2 ± 1.8 nmol/L in PHA-stimulated PBMC cultures. Viability of cells was not affected 
by the treatment with 10 µg/ml PHA for 48 hours (data not shown). 
 
Fig. 1.  A) Kynurenine to tryptophan ratio (Kyn/trp) and B) neopterin concentrations 
expressed as % of baseline in the supernatants of unstimulated (open circles) 
and phytohaemagglutinin (PHA)-stimulated PBMC (closed triangles) pretreated 
or not with increasing concentrations of Crinum latifolium leave extract for 48 
hours. Results shown are the mean values ± S.E.M. of four independent 
experiments run in duplicates (*p <0.05). 
Treatment of PBMC with increasing concentrations of Crinum latifolium extracts for 48 
hours, suppressed tryptophan degradation mediated by IDO activity (kyn/trp) in a dose-
dependent manner in unstimulated- and PHA-stimulated cultures with IC50's of 241 ± 57 
µg/ml (~1.2 µg/ml total alkaloids; 0.07 µg/ml crinamidine) and 92 ± 20 µg/ml (~0.5 µg/ml 
total alkaloids; 0.03 µg/ml crinamidine), respectively (Fig. 1A). At doses of 250 µg/ml, the   Crinum Latifolium Leave Extracts Suppress Immune Activation Cascades in Peripheral Blood …  327 
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extract almost completely suppressed mitogen-induced IDO activity (kyn/trp; Fig. 1A). 
Measurement of neopterin concentrations showed, that the extract only slightly, but 
significantly reduced neopterin production in unstimulated PBMC supernatants, whereas 
PHA-stimulated neopterin formation was suppressed in a dose-dependent manner with an 
IC50 of 453 ± 86 µg/ml (~2.3 µg/ml total alkaloids; 0.13 µg/ml crinamidine; Fig. 1B). No 
influence on the viability of PBMC, even at the highest concentrations tested, could be 
detected after 48 hours of treatment (data not shown). 
Antiproliferative activity 
Treatment of human prostate carcinoma PC3 and LNCaP cells, and also benign prostate 
hyperplasia BPH-1 cells with water extracts of Crinum latifolium, showed a significant and 
dose-dependent inhibition of cell growth after a culture period of 72 hours (Fig. 2A). 
Parallel measurements of growth inhibition after treatment of cells with cisplatin were used 
as a positive control (Figure 2B). The most sensitive cell line affected by these treatments 
were BPH-1 cells, whose proliferation was inhibited with an IC50 of 2120 ± 41 µg/ml (~10.6 
µg/ml total alkaloids; 0.6 µg/ml crinamidine) after treatment with Crinum latifolium extract 
and with an IC50 of 2.3 ± 0.3 nM after treatment with cisplatin. 
 
Fig. 2.   Viability of PC3- (open triangles), BPH-1- (open squares) and LNCaP-cells 
(open circles) after treatment with or without increasing concentrations of 
Crinum latifolium leave extract (A) or cisplatin (B) for 72 hours, expressed as % 
of baseline. Results shown are the mean values ± S.E.M. of three independent 
experiments run in duplicates (*p <0.05). 
The growth of PC3 and LNCaP cells was suppressed by the Crinum latifolium extract at 
IC50-doses of 4540 ± 791 µg/ml (~22.7 µg/ml total alkaloids; 1.3 µg/ml crinamidine) and 
2344  ±  148 µg/ml (~11.7 µg/ml total alkaloids; 0.7 µg/ml crinamidine), respectively. 
Cisplatin showed potent antiproliferative effects on PC3 and LNCaP cells at IC50-doses of 
6.3 ± 0.8 nM and 5.5 ± 0.9 nM, respectively. 
It is unclear, which compounds of the Crinum latifolium leave extract are responsible for 
the effects on stimulated PBMC or proliferation of prostate cells. Obviously, the active 
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and it appears that antioxidant compounds (represented by a high ORAC value of the 
extract) and/or specific alkaloids could play a more relevant role. Phytochemical analysis 
of  Crinum species revealed more than 170 different compounds, most of which are 
alkaloids of the Amaryllidaceae type, which exhibit a wide range of biological activity such 
as analgesic, central nervous system, antitumor, and antiviral effects [1,  28]. Although 
chemical analysis of Crinum latifolium alkaloids have been performed mainly on bulbs, 
which contain the highest concentrations of alkaloids, the presence of alkaloids, especially 
of the crinane type e.g. crinamine, crinamidine, crinafoline and crinafolidine, were also 
detected in water extracts of Crinum latifolium leaves [29]. The extract used in this study 
was standardized to contain 0.3 µg crinamidine/mg of dry extract. With respect to the 
results obtained in this study, we speculate on a possible involvement of such crinane-
type Amaryllidaceae alkaloids, since they have been shown earlier to possess anticancer 
activity by inducing apoptosis and at the same time exhibit low toxicity to healthy cells, 
such as mono-nucleated blood cells [30, 31]. 
Th1-type cytokine IFN-γ induces activation of IDO in macrophages as well as in other cells 
including tumor cells such as prostate, colorectal, pancreatic and cervical carcinomas, 
some of which have been shown to constitutively express IDO [32]. Although IFN-γ 
production and activation of IDO aims to inhibit the growth of malignant cells and should 
primarily contribute to tumor rejection, IDO also attenuates T-cell proliferation and 
consequently the immune response. Thus, beside its role in antimicrobial host defense, 
IDO plays also an important role as an effector mechanism of the antitumor immune 
response [33, 34]. However, this immunosuppressive aspect of IDO may enable tumor 
cells to evade and overcome control by the immune system. Thereby, IDO activity could 
contribute to the development of immunodeficiency – a major reason for disease 
progression and death, especially in the latter course of cancer.  
A beneficial effect of IDO suppression on tumor growth by specific inhibitors was shown in 
various animal models. Friberg et al. demonstrated an enhancing effect of the small 
molecule inhibitor 1-methyl tryptophan (1MT) on T-cell activity in vitro and additionally, a 
capacity of 1MT to retard growth of Lewis lung carcinoma (LLC) cells in syngeneic mice 
[35]. Uyttenhove et al. showed that ectopic expression of IDO by immunogenic mouse 
tumor cells promotes tumor growth in preimmunized mice, which could partially be 
reversed by systemic treatment with 1MT [33]. Using the MMTV-neu/HER2 transgenic 
mouse model of breast cancer, Muller and coworkers showed also that 1MT slightly 
retarded tumor outgrowth, whereas combinatory treatment with 1MT and paclitaxel or 
other chemotherapeutics caused rapid regression of established tumors, which was 
abrogated in athymic or T-cell depleted mice [36]. Further IDO inhibitors such as 
methylthiohydantoin-tryptophan (MTH-trp) or the phytoalexin brassinin were also shown to 
exert a similar pattern of antitumor activity [36–38]. 
In conclusion, the finding of a strong suppressive effect of Crinum latifolium leave extract 
on IDO activity in stimulated and resting PBMC, may represent a new aspect in the 
understanding of the antitumor activities of Crinum latifolium. In addition, an inhibitory 
effect on prostate tumor cells was demonstrated. In the aggregate, both effects, inhibition 
of tumor cell growth and recovery of immune functions, may contribute to the reported 
beneficial effects of Crinum latifolium in the treatment of prostate tumors. Further studies 
are needed to demonstrate whether our in vitro findings can be transferred to the in vivo 
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Experimental 
Preparation of the aqueous Crinum latifolium extract 
The dry extract of Crinum latifolium leaves from CriLa® capsules (250 mg), obtained by 
the Thien Duoc Company Ltd. (Ho Chi Minh City, Vietnam), was standardized with 
reference to the amount of crinamidine content (70 µg/capsule) using reverse phase high 
performance liquid chromatography (HPLC; Figure 3). Content of total alkaloids was also 
measured by HPLC and calculated with reference to lycorin, which revealed 1.25 ± 0,13 
mg total alkaloids/capsule. Leaves from Crinum latifolium L. were collected in April and 
July at the District of Go Vap, Ho Chi Min City, Vietnam. A voucher specimen is kept at the 
Nguyen Thi Ngoc Tkam Herbarium. The identity of the plant was confirmed by Prof. Dr. 
Sc. Tkan Cong Khanh, Department of Botany, Hanoi College of Pharmacy, Center for 
Research and Development of Ethnomedicinal Plants (CREDEP). In this study, 250 mg of 
the dry powder of a CriLa® capsule was extracted for 1 hour using 50 ml of cell culture 
media (RPMI) at room temperature. Thereafter, the extract was sterile filtered and stored 
at room temperature until analysis. 
 
Fig. 3.   HPLC chromatogram of crinamidine standard (RT 33 min; A), and the dry 
extract of Crinum latifolium leaves (B). 
Cell culture 
PBMC were isolated from whole blood obtained from healthy donors, of whom informed 
consent was obtained that their donated blood unit was used for scientific purposes if not 
otherwise used. Separation of blood cells was performed using density centrifugation 
(Lymphoprep, Nycomed Pharma AS, Oslo, Norway). After isolation, PBMC were washed 
three times in phosphate buffered saline containing 0.2% EDTA [0.5 mmol/L]. Cells were 330 M.  Jenny  et al.:  
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maintained in RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum 
(Biochrom, Berlin, Germany), 1% of 200 mmol/L glutamine (Serva, Heidelberg, Germany) 
and 0.1% of gentamicin (50 mg/ml, Bio-Whittaker, Walkersville, MD) in a humidified 
atmosphere containing 5% CO2 for 48h. This procedure was observed earlier to reveal 
best reproducible results when applied for testing of anti-inflammatory effects of 
compounds or drugs [39]. Average tryptophan content in the supplemented RPMI 1640 
medium was 31.5 µmol/L. For each of the four experiments run in duplicates, PBMC were 
freshly prepared. Isolated PBMC were plated at a density of 1.5 x10
6 cells/ml in 
supplemented RPMI 1640, preincubated for 30 minutes with or without aqueous Crinum 
latifolium leave extracts and stimulated or not with 10 µg/ml PHA for 48h. Prostate 
carcinoma PC-3 cells were grown in Coon's F12 Modified Medium (Biochrom, Berlin, 
Germany) supplemented with 7% FCS, 4 mM L-glutamine and 50 µg/ml gentamycin. 
Benign prostatic hyperplasia (BPH-1)- and androgen-sensitive human prostate 
adenocarcinoma LNCaP cells were grown in RPMI 1640 (Biochrom, Berlin, Germany) 
supplemented with 10% FCS, 4 mM L-glutamine and 50 µg/ml gentamycin. Cells were 
maintained in a humidified atmosphere containing 5% CO2. 
Oxygen radical absorbance capacity (ORAC) assay 
The capacity of the aqueous Crinum latifolium extract to scavenge peroxyl radicals was 
evaluated by the ORAC assay using the protocol of Ou. et al. [40]. Briefly, the final assay 
mixture (0.2 ml total volume) contained 6.3 x 
−8 M fluorescein (AnaSpec, USA) as a target 
of free radical attack and 1.9 x 10
−2 M 2,2'-azobis(2-amidinopropane) dihydrochloride 
(AAPH, Wako Chemicals, Germany), which decomposes in aqueous solutions at 37°C and 
generates alkyl radicals (R´•) that are converted into the corresponding peroxyl radicals 
(R´OO•) in the presence of oxygen. 75 mM phosphate buffer served as a blank, and 6-
hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox, a synthetic water-soluble 
analogue of vitamin E, Sigma-Aldrich, Austria) was used as the control standard. The 
fluorescence of fluorescein was recorded at 37°C by a fluorometer (Fluoroscan Ascent, 
Labsystems; 485/535nm). During an assay period of 35 min the decrease of fluorescence 
was measured in minute intervals after the addition of AAPH. Final results were calculated 
using the differences between areas under the fluorescein decay curves (AUC) of blank 
and sample. The protective effect of a putative antioxidant was calculated by comparing 
the AUC of the sample with that of Trolox. The final ORAC values were expressed as µmol 
Trolox equivalents per gram of dried powder (µmol TE/g). 
Measurement of tryptophan, kynurenine and neopterin concentrations 
After incubation of cells for 48h, supernatants were harvested by centrifugation and 
tryptophan and kynurenine concentrations were determined by HPLC using 3-nitro-L-
tyrosine as an internal standard [41]. To estimate IDO enzyme activity, kyn/trp was 
calculated and expressed as µmol kynurenine/mmol tryptophan. Neopterin concentrations 
were determined by an enzyme-linked immunosorbent assay (ELISA; BRAHMS, 
Hennigsdorf/Berlin, Germany) according to the manufacturer’s instructions with a detection 
limit of 2 nmol/L.  
Measurement of cell viability 
After incubation of PBMC with increasing concentrations of Crinum latifolium extract, the 
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was measured by reduction of the tetrazole 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) (Sigma Aldrich, Vienna, Austria), which is reduced to purple 
formazan in living cells, and by trypan blue exclusion method in three experiments done in 
triplicate. No toxicity of the Crinum latifolium extract could be observed in PBMC at the 
concentration range applied [0.1–2.5 mg/ml]. After incubation of PC3-, BPH-1- or LNCaP-
cells with increasing concentrations of Crinum latifolium extract [0.25–5 mg/ml] or cisplatin 
[0.1–10 nM] for 72 hours, cell viability was measured with Cell Titer Blue reagent 
(Promega, Mannheim, Germany), which measures metabolic activity of living cells by 
reduction of resazurin to resofurin. These experiments were performed in three 
independent experiments done in duplicates. 
Statistical analysis 
For statistical analysis, the Statistical Package for the Social Sciences (version 14 SPSS, 
Chicago, Ill, USA) was used. Because not all data sets showed normal distribution, for 
comparison of grouped data non-parametric Friedman test and Wilcoxon signed ranks test 
were applied. P-values below 0.05 were considered to indicate significant differences. 
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